UKCMRI Taps Sir Paul Nurse as Inaugural Director and Chief Executive | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The UK Centre for Medical Research and Innovation has appointed the chair of its Scientific Planning Committee to be its inaugural director and chief executive, effective Jan. 1, 2011.

Sir Paul Nurse, a Nobel laureate and the president of New York's Rockefeller University since 2003, will oversee the institute's projected 1,500 employees, including 1,250 scientists, and an annual operating budget estimated at £100 million ($153.7 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.